Company intelligence / Profile preview

European Biotech Acquisition

Amsterdam, Netherlands

Ownership: Private
Development stage: Other

Overview

European Biotech Acquisition Corp was a special purpose acquisition company (SPAC) focused on acquiring a company in the European life sciences/biotech sector, ultimately combining with Oculis in March 2023 to create Oculis Holding AG[4].

Industry: Investors

Partnerships

Life Sciences Partners (SPAC sponsor, major healthcare investment firm)[2]

Beyond the preview

Go deeper on European Biotech Acquisition.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on European Biotech Acquisition.

Explore the full profile